Friday, June 16, 2017 10:16:00 AM
Three new board of directors were listed on the most recent 8-k:
Rufus (Rudy) Williams - Chief Operating Advisor
Dr. John H. Abeles - Senior Executive Advisor
Dr. Vincent Ahonkhai - Senior Regulatory Advisor
You can look up all of them, but the most important (in my opinion) of the three is Dr. Vincent Ahonkhai.
As some people on this message board have heard rumors (Noreen mentioned it during the January conference call), the GATES FOUNDATION will be helping Immune Therapeutics by funding initial purchase orders. This has not been confirmed in any publications and has not been documented anywhere, so it is hearsay.
However! Dr. Vincent Ahonkhai is IMUN's new Senior Regulatory Advisor. This is really amazing news, because he is also the Senior Regulatory Advisor for the BILL AND MELINDA GATES FOUNDATION! This tells me that the rumors are likely the truth. And this is huge!
https://www.researchgate.net/profile/Vincent_Ahonkhai
http://www.zoominfo.com/p/Vincent-Ahonkhai/2428292
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM